https://investor.ironwoodpharma.com/press-releases/press-release-details/2010/Almirall-and-Ironwood-Announce-Positive-Results-from-the-Second-Phase-3-Trial-of-Linaclotide-in-Patients-with-Irritable-Bowel-Syndrome-with-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- November 1, 2010